Combined administration of antibodies to human interleukin 8 and epidermal growth factor receptor results in increased antimetastatic effects on human breast carcinoma xenografts

Clinical Cancer Research

Volumn 8, Issue 8, 2002, Pages 2655-2665

  Salcedo, Rosalba ^a   Martins Green, Manuela ^c   Gertz, Barry ^a   Oppenheim, Joost J ^a   Murphy, William J ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; INTERLEUKIN 8 ANTIBODY; MATRIX METALLOPROTEINASE; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY; ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE; GELATINASE B; INTERLEUKIN 8;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; BREAST METASTASIS; CANCER GROWTH; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; BREAST TUMOR; CANCER TRANSPLANTATION; CELL CULTURE; CELL DIVISION; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOLOGY; METABOLISM; METASTASIS; MOUSE MUTANT; PHOSPHORYLATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; SERODIAGNOSIS; TIME;

ANIMAL; ANTIBODIES; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMAL GROWTH FACTOR; FEMALE; FLOW CYTOMETRY; GELATINASE B; GELATINASES; HUMAN; IMMUNOBLOTTING; INTERLEUKIN-8; MICE; MICE, SCID; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PHOSPHORYLATION; PRECIPITIN TESTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; TUMOR CELLS, CULTURED; ANIMALS; HUMANS; MATRIX METALLOPROTEINASE 9;

EID: 0036023431     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-κB signal pathways
2. Interleukin-8 delays spontaneous and tumor necrosis factor-α-mediated apoptosis of human neutrophils
3. TNFα-induced suppression of PMN apoptosis is mediated through interleukin-8 production
4. Induction of apoptosis and cell cycle arrest by CP-358, 774, an inhibitor of epidermal growth factor receptor tyrosine kinase
5. Epidermal growth factor receptor in human breast cancer: Correlation with cytosolic and nuclear ER receptors and with biological and histological tumor characteristics
6. Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin
7. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts
8. The epidermal growth factor receptor as a target for therapy in breast carcinoma
9. Immunotherapy with antibodies to the EGF receptor
10. The human EGF receptor as a target for cancer therapy: Six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468
11. Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction
12. Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer
13. IL-8 reduced tumorigenicity of human ovarian cancer in vivo due to neutrophil infiltration
14. Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer
15. Interleukin-8 as a macrophage-derived mediator of angiogenesis
16. Interleukin-8. A corneal factor that induces neovascularization
17. Interleukin-8 stimulates angiogenesis in rats
18. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice
19. A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells
20. Human endothelial cells express CCR2 and respond to MCP-1: Direct role of MCP-1 in angiogenesis and tumor progression
21. Involvement of chemokine receptors in breast cancer metastasis
22. Molecular portraits of human breast tumours
23. Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy
24. Fully human anti-interleukin-8 monoclonal antibodies: Potential therapeutics for the treatment of inflammatory disease states
25. Inhibitory effect of anti-epidermal growth factor receptor antibody on a human gastric cancer
26. Differentiation or immune destruction: Two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor
27. Localization of epidermal growth factor precursor in tooth and lung during embryonic mouse development
28. Distribution of epidermal growth factor receptor and ligands during bronchiolar epithelial repair from naphthalene-induced Clara cell injury in the mouse
29. Impaired lung branching morphogenesis in the absence of functional EGF receptor
30. Expression and localization of epidermal growth factor, transforming growth factor-α, and localization of their common receptor in fetal human lung development
31. Heparin-binding EGF-like growth factor: Characterization of rat and mouse cDNA clones, protein domain conservation across species, and transcript expression in tissues
32. Epigenetic role of epidermal growth factor expression and signalling in embryonic mouse lung morphogenesis
33. Immunolocalization of transforming growth factor-α, epidermal growth factor (EGF), and EGF-receptor in normal and injured developing human lung
34. Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells
35. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis
36. Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association
37. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis
38. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: Relevance to stability of atherosclerotic plaque
39. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane
40. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion
41. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells
42. Molecular aspects of invasion and metastasis of stomach cancer
43. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice
44. Expression of interleukin-8 in primary and metastatic malignant melanoma of the skin
45. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8
46. Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma
47. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer
48. Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin
49. Role of interleukin-8 in tumor growth and metastasis of human melanoma
50. New agents in cancer clinical trials